• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

High recurrence of lymphedema and influencing factors in discharged breast cancer patients during the COVID ‐19 pandemic: A multicenter, cross‐sectional survey
ConclusionDuring the COVID-19 pandemic, high prevalence of lymphedema was observed in patients Age, radical surgery and fully completed radiotherapy were associated with increased risk of severer lymphedema. Meanwhile, the patients with severe lymphedema experienced psychological distress. While the Covid-19 pandemic was still raging, continuous efforts should be made to identify patient at risk of lymphedema and distribute feasible guidance and education for self-management in lymphedema.
Source: Cancer Medicine - May 11, 2022 Category: Cancer & Oncology Authors: Xin Peng, Renwang Chen, Zhenli Rao, Yi Yang, Yunli Yan, Ying Xia, Ting Wang, Jianying Wang, Fang Lu, Hong Pan, Yan Liu, Jing Cheng, Qin He Tags: RESEARCH ARTICLE Source Type: research

Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan
CONCLUSION: Here, we collected the diagnosis and treatment process of patients with breast cancer in our center during the coronavirus disease 2019 pandemic, which was found to be correlated to a reduction in chemotherapy-related myelosuppression and hepatic dysfunction, hoping to provide a reference for other cancer centers that may suffer from the similar situation.PMID:34078565 | DOI:10.1016/j.clbc.2021.04.014
Source: Clinical Breast Cancer - June 3, 2021 Category: Cancer & Oncology Authors: Jun Zhou Yuyin Liu Ming Xu Li Mei Shengnan Ruan Ning Zhang Pengfei Yi Qianzhi Chen Jie Tan Source Type: research

Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint
Breast cancer is the most common malignant tumor in women globally. Currently, due to limited data, there are no international guidelines for addressing the management of a large group of patients during infectious disease pandemics. Coronavirus disease 2019 (COVID-19), declared as a pandemic by the World Health Organization (WHO), has rapidly spread globally. The COVID-19 pandemic changed our daily routines and forced us to rethink the management of breast cancer patients. Clinicians need to take into account multiple factors such as the timing and delivery of cancer care, epidemic prevention and control, and the allocati...
Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Wan Wang, Baoliang Guo, Chunguo Cui, Tong Sun, Shengnan Liu Tags: Review Source Type: research

The Impact of the COVID-19 Pandemic on Breast Imaging.
This article summarizes the effect of the global pandemic-and efforts to curtail its spread-on both breast cancer care and on breast imaging practices including effects on patients, clinical workflow, education, and research." PMID: 33222992 [PubMed - in process]
Source: Clinical Breast Cancer - November 24, 2020 Category: Cancer & Oncology Authors: Freer PE Tags: Radiol Clin North Am Source Type: research

Asymptomatic COVID-19 infection in patients with cancer at a cancer-specialized hospital in Wuhan, China - Preliminary results.
CONCLUSIONS: Our study shows that the lymphocytes of 100% of asymptomatic carriers were in the normal range. This result indicates that the host immunity of asymptomatic carriers is not significantly disrupted by COVID-19. Single PCR detection is not sufficient to screen among asymptomatic individuals, and a combination of PCR tests, serological tests and CT is of great importance. Unless the tumour is life-threatening or rapidly progressing, we advise restarting active anti-tumour therapy after PCR tests become negative. PMID: 33015823 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - October 7, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research

The impact of the COVID-19 pandemic on Breast Imaging
This article summarizes the effect of the global pandemic – and efforts to curtail its spread – on both breast cancer care and on breast imaging pract ices including effects on patients, clinical workflow, education and research.
Source: Radiologic Clinics of North America - September 21, 2020 Category: Radiology Authors: Phoebe E. Freer Source Type: research

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
Conclusion: This study will provide comprehensive evidence for medical staff to adopt effective treatment strategies for breast cancer patients during the COVID-19 pandemic. PROSPERO registration number: CRD42020188208.
Source: Medicine - July 31, 2020 Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research

Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China
ConclusionsThis commentary focused on breast cancer patients and provided suggestions to avoid the spread of COVID-19. Some of these suggestions are also suitable for cancer patients in other lesions. We hope our suggestions are useful to oncologists in other countries and help them to overcome this challenge.
Source: Breast Cancer Research and Treatment - July 23, 2020 Category: Cancer & Oncology Source Type: research

Acute arterial thrombosis in a breast cancer survivor with coronavirus disease 2019 (COVID-19)
The coronavirus disease 2019 (COVID-19) outbreak caused by the novel coronavirus (SARS-CoV-2), which originated in Wuhan (China), has now spread across the globe affecting millions of people worldwide.1 COVID-19 is a hypercoagulable state and may lead to both venous and arterial thromboembolic events.2 This state is more common in cancer patients owing to an immunosuppressed state.3 Therefore, a thorough evaluation of the vascular system is warranted in these patients.
Source: Surgery - July 6, 2020 Category: Surgery Authors: Sandeep Bhoriwal, Kunal Dhall, Prafull Kumar Gamit, S.V.S. Deo Source Type: research

I ’m a Doctor Recovering From COVID-19. I Can’t Get Over the Government’s Callousness for Human Life
Dr. Laura Mulvey, 33, practices emergency medicine at Maimonides Medical Center in Brooklyn, New York. After spending six days receiving treatment in her own hospital, she is now recovering at home from what is presumed to be COVID-19, though her test was inconclusive. What follows is a lightly-edited transcript of her story as told to TIME. Early on, sometime in February, [COVID-19] was something that people were thinking about. And worried about. Certainly, the worries were not what they are now. But hospital-wise, we had a bit of an earlier jump on it, because we recognized that this was a potential threat. We’re ...
Source: TIME: Health - March 30, 2020 Category: Consumer Health News Authors: Dr. Laura Mulvey Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news